Back to search results

Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer

Abroad (travel likely)Recruiting

Conditions

Localized Prostate Carcinoma · Prostate Cancer (Adenocarcinoma) · Prostate Hyperplasia · Lower Urinary Track Symptoms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Klinik für Radioonkologie und Strahlentherapie, Universitätsklinikum Heidelberg, Heidelberg, Baden-Wurttemberg, Germany

    Contact: Study coordinator (Jürgen Debus, Prof. Dr. med. Dr. rer. nat.) · juergen.debus@med.uni-heidelberg.de
    Contact: Principal Investigator (Jürgen Debus, Prof. Dr. med. Dr. rer. nat.)

  • Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Universitätsklinikum LMU, Munich, Bavaria, Germany

    Contact: Study coordinator (Claus Belka, Prof. Dr. med.) · Claus.Belka@med.uni-muenchen.de
    Contact: Principal Investigator (Claus Belka, Prof. Dr. med.)

  • University Hospital Zurich, Department of Radio-Oncology, Zurich, Canton of Zurich, Switzerland

    Contact: Study coordinator (Matthias Guckenberger, Prof. Dr. med.) · matthias.guckenberger@usz.ch · +41 44 255 31 50
    Contact: Principal Investigator (Tiuri E. Kroese, MD PhD)
    Contact: Principal Investigator (Matthias Guckenberger, Prof. Dr. med.)
Study leads

  • Matthias Guckenberger, Prof. Dr. med.

    Study Chair

    University of Zurich

  • Tiuri E. Kroese, MD, PhD

    Principal Investigator

    University of Zurich

  • Matthias Guckenberger

    Principal Investigator

    University of Zurich

View source on ClinicalTrials.gov(opens in a new tab)